Skip to main content
Fig. 4 | Insights into Imaging

Fig. 4

From: Comparison contrast-enhanced CT with contrast-enhanced US in diagnosing combined hepatocellular-cholangiocarcinoma: a propensity score-matched study

Fig. 4

CEUS and CECT images of a 56-year-old man with chronic hepatitis B and CA 19-9 < 100 U/mL. A 7.3-cm mass was detected in segment IV of the liver (A). A hypoechoic mass with poor boundary on conventional ultrasound (A, a); on CEUS, the mass showed hyperenhancement, a nonsmooth tumor margin (stars), and tumor supply artery (arrowhead) at 18 s (A, b); in the late phase (179 s), the hyperenhanced area in the arterial phase of mass exhibited partial washout with partial isoenhancement (stars) and partial hypoenhancement area (arrowhead, A, c). Based on these features, the likelihood of this mass being diagnosed as cHCC-CCA was smaller than 30% according to the CEUS-predominant model (B). There was no obvious cirrhotic liver background, and the mass showed low density on abdominal CT image (A, d), rim enhancement and < 50% nonrim enhancement (mainly the right posterior part of the lesion, arrow) in the arterial phase (A, e), “washout” absence, nonsmooth tumor margin, and a thin incomplete enhanced capsule (arrow) seen in the portal venous phase (A, f). Based on these features, the likelihood of this mass being diagnosed as cHCC-CCA was higher than 90.0% according to the CECT-predominant model (C). The mass was pathologically proven to be combined hepatocellular-cholangiocarcinoma

Back to article page